Covid-19 roundup: Moderna CEO Stéphane Bancel becomes a billionaire; Novartis, Incyte pitch Jakafi PhIII to tackle severe cases
You can now add Moderna CEO Stéphane Bancel to the list of biotech billionaires.
Since investors began to understand the full scope of the coronavirus outbreak in late February, cash has flushed out of much of the stock market and into the handful of companies leading the fight for drugs and vaccines. That’s meant hundreds of millions for Moderna, the Flagship-backed company that emerged early as the world’s first best hope for a Covid-19 vaccine.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 109,500+ biopharma pros reading Endpoints daily — and it's free.